QUANTUM BIOPHARMA LTD.
NASDAQ: QNTM (Quantum Biopharma Ltd.)
最近更新时间: 昨天, 3:45PM8.91
0.32 (3.73%)
| 前收盘价格 | 8.59 |
| 收盘价格 | 8.04 |
| 成交量 | 40,763 |
| 平均成交量 (3个月) | 125,265 |
| 市值 | 34,713,324 |
| 价格/销量 (P/S) | 91.86 |
| 股市价格/股市净资产 (P/B) | 18.36 |
| 52周波幅 | |
| 利润日期 | 12 Aug 2025 - 18 Aug 2025 |
| 稀释每股收益 (EPS TTM) | -13.22 |
| 总债务/股东权益 (D/E MRQ) | 28.27% |
| 流动比率 (MRQ) | 0.960 |
| 营业现金流 (OCF TTM) | -9.16 M |
| 杠杆自由现金流 (LFCF TTM) | -3.67 M |
| 资产报酬率 (ROA TTM) | -71.24% |
| 股东权益报酬率 (ROE TTM) | -268.81% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Quantum Biopharma Ltd. | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.00 |
|
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 11.41% |
| 机构持股比例 | 23.49% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Advisorshares Investments Llc | 30 Sep 2025 | 37,237 |
| Cetera Trust Company, N.A | 30 Jun 2025 | 250 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合